Biopsy News and Research

RSS

Biopsy is the removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy.

Presentations at Tuesday's RSNA conference

A new study from Cincinnati Children's Hospital Medical Center reports that beverage can stay-tabs pose a potential ingestion risk. In the 1970s, U.S. manufacturers switched to the stay-tab design after safety concerns about pull-tabs. The new study found 19 cases of stay-tab ingestion at a single institution, mainly among teenagers.

30 Nov 2009

Royal Philips Electronics demonstrates its portfolio of dose radiation managing products

Royal Philips Electronics today announced its response to an industry need by showing its portfolio of products designed to manage dose radiation at this year's 95th annual meeting of the Radiological Society of North America (RSNA) in Chicago.

From Philips Healthcare 30 Nov 2009

Siemens Healthcare to showcase latest medical imaging technologies at RSNA 2009

At the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), "Images, my way" will resonate throughout the Siemens Healthcare booth (#825) from November 29 to December 3 at McCormick Place (Booth #825, East Building/Lakeside Center, Hall D) in Chicago.

30 Nov 2009

Elastography decreases breast biopsies and maps tumors more precisely

Elastography is an effective, convenient technique that, when added to breast ultrasound, helps distinguish cancerous breast lesions from benign results, according to an ongoing study presented today at the annual meeting of the Radiological Society of North America (RSNA).

30 Nov 2009

Siemens Healthcare to introduce high-end imaging systems for interventional oncological procedures at RSNA 2009

At the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from November 29 to December 3 at McCormick Place in Chicago, Siemens Healthcare will introduce its comprehensive portfolio for imaging in interventional oncology at booth #825, East Building/Lakeside Center, Hall D.

30 Nov 2009

VIDA Diagnostics and Veran Medical to develop and market endobronchial lung navigation and biopsy system

VIDA Diagnostics, a leading developer of quantitative imaging software for the advanced analysis of pulmonary diseases, and Veran Medical Technologies, a leader in minimally invasive delivery of interventional oncology therapies, announced the companies have signed a definitive agreement covering joint development and distribution of an endobronchial lung navigation and biopsy system.

30 Nov 2009

Aegis Breast 3.0 that offers powerful real-time 4D image processing to be launched

Sentinelle Medical Inc., a leading manufacturer of breast MRI coils and advanced visualization software launches a suite of new leading edge clinical applications on its Aegis(TM) medical imaging software platform at this year's Radiological Society of North America (RSNA) annual meeting in Chicago, Nov. 30 - Dec. 5, 2009 (Booth 5800, Hall A).

26 Nov 2009

SBI urges Congress to exclude the USPSTF guidelines from health care legislation

Several sections of Senate health care reform legislation contain language stipulating that insurance entities such as private insurers, Medicare and Medicaid would only be required to cover services receiving a specific grade from the U.S. Preventative Services Task Force. Presently, this would exclude mammography services for women 40-49, would only require coverage of biennial (every other year) coverage for women 50-74, and exclude coverage for those 74 and older.

25 Nov 2009

Comparison study finds no significant differences in post-transplant survival rates of NASH and ETOH groups

Researchers at the University of Miami School of Medicine compared the outcomes of cirrhotic patients who underwent liver transplants for nonalcoholic steatohepatitis (NASH) versus alcoholic liver disease (ETOH) and found no statistically significant differences in post-transplant survival rates between the NASH and ETOH groups

25 Nov 2009

Guardian Technologies' novel imaging analysis technology platforms may help avoid mammography false positives

Guardian Technologies International, Inc. -- A recent U.S. Preventive Services Task Force report suggests that while mammograms save lives, they also lead to unnecessary additional procedures. Experts suggest that the problem with mammography is that improvements are needed to reduce false positives and increase accuracy.

24 Nov 2009

DSS sets evidence-based guidelines and definitions to treat type 2 diabetes

A first-of-its-kind consensus statement on diabetes surgery is published online today in the Annals of Surgery. The report illustrates the findings of the first international consensus conference -- Diabetes Surgery Summit (DSS) -- where an international group of more than 50 scientific and medical experts agreed on a set of evidence-based guidelines and definitions that are meant to guide the use and study of gastrointestinal surgery to treat type 2 diabetes. The document is considered to be the foundation of diabetes surgery as a medical discipline of its own.

24 Nov 2009

Absolute Match DNA specimen verification test introduced by AIBioTech

American International Biotechnology Services™ announces the launch of its Absolute Match™ DNA specimen verification test. The test, which will be performed through AIBioTech’s Fairfax Identity Laboratories™ division, provides absolute confidence for a patient undergoing a biopsy procedure that their specimen and diagnosis is their own.

23 Nov 2009

AdnaTest BreastCancer Select & Detect kit now available in the Czech Republic and Slovakia

OncoVista Innovative Therapies, Inc., reported that the AdnaTest BreastCancer Select & Detect kit, manufactured by AdnaGen AG (Langenhagen, Germany), is now available for research as well as for pay-out-of-pocket patients in the Czech Republic and Slovakia.

23 Nov 2009

Scientists discover new potential target for treating non-Hodgkin's lymphoma

Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, or white blood cells. By exploiting this mechanism, researchers have been able to powerfully suppress tumor formation in lab testing and in animal models.

22 Nov 2009

Short-term follow-up a reasonable alternative to biopsy of palpable breast lesions

Short-term follow-up is a reasonable alternative to invasive biopsy of palpable (capable of being touched or felt) breast lesions with benign imaging features, particularly in younger women with probable fibroadenoma (non-cancerous tumors that often occur in women during their reproductive years), according to a study published in the December issue of the American Journal of Roentgenology.

21 Nov 2009

ACS' mammography screening guidelines receives support from ACoS

The American College of Surgeons (ACoS) today released comments strongly supporting current American Cancer Society (ACS) screening mammography guidelines that recommend women get a mammogram every year, starting at age 40.

20 Nov 2009

"Micro-endoscopes" to detect tumors at earlier stages being developed

Traditional endoscopes provide a peek inside patients' bodies. Now, a University of Florida engineering researcher is designing ones capable of a full inspection.

19 Nov 2009

Researchers develop new device with nano-sized features to grab cancer cells

Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor.

19 Nov 2009

iCAD and AdMeTech Foundation sign a strategic partnership agreement

iCAD, Inc., an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, today announces a strategic partnership with the AdMeTech Foundation, a non-profit organization with a mission to end prostate cancer as a patient care crisis and socio-economic problem.

19 Nov 2009

Interim data from an ongoing phase 1 dose-escalation trial of XL147 reported

Exelixis, Inc. today reported interim data from an ongoing phase 1 dose-escalation trial of XL147 (SAR245408) in combination with the EGFR inhibitor erlotinib in patients with advanced solid tumors.

19 Nov 2009

Biopsy News and Research

Further Reading

Presentations at Tuesday's RSNA conference

Royal Philips Electronics demonstrates its portfolio of dose radiation managing products

Siemens Healthcare to showcase latest medical imaging technologies at RSNA 2009

Elastography decreases breast biopsies and maps tumors more precisely

Siemens Healthcare to introduce high-end imaging systems for interventional oncological procedures at RSNA 2009

VIDA Diagnostics and Veran Medical to develop and market endobronchial lung navigation and biopsy system

Aegis Breast 3.0 that offers powerful real-time 4D image processing to be launched

SBI urges Congress to exclude the USPSTF guidelines from health care legislation

Comparison study finds no significant differences in post-transplant survival rates of NASH and ETOH groups

Guardian Technologies' novel imaging analysis technology platforms may help avoid mammography false positives

DSS sets evidence-based guidelines and definitions to treat type 2 diabetes

Absolute Match DNA specimen verification test introduced by AIBioTech

AdnaTest BreastCancer Select & Detect kit now available in the Czech Republic and Slovakia

Scientists discover new potential target for treating non-Hodgkin's lymphoma

Short-term follow-up a reasonable alternative to biopsy of palpable breast lesions

ACS' mammography screening guidelines receives support from ACoS

"Micro-endoscopes" to detect tumors at earlier stages being developed

Researchers develop new device with nano-sized features to grab cancer cells

iCAD and AdMeTech Foundation sign a strategic partnership agreement

Interim data from an ongoing phase 1 dose-escalation trial of XL147 reported

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News